AMSTERDAM, the Netherlands—For hemodynamically stable patients with STEMI and multivessel coronary artery disease, those who receive immediate complete revascularization fare just as well as those who ...

Advances in the treatment of coronary artery disease remained steady in 2025, as in recent years, but the past 12 months also ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. Primary PCI should continue to be the standard of care ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. Antiplatelet therapy with ticagrelor after primary PCI ...

(HealthDay News) – Patients with ST-segment elevation myocardial infarction (STEMI) who are taken directly to a percutaneous coronary intervention (PCI)-capable hospital, even if they have to bypass a ...

SAN DIEGO, CA — A large trial in patients with acute coronary syndrome (ACS), including patients with and without ST-segment elevation MI (NSTEMI and STEMI), shows that a coronary intervention ...

Share on Facebook. Opens in a new tab or window Share on Bluesky. Opens in a new tab or window Share on X. Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window PHILADELPHIA -- ...

It's best to have patients on aggressive lipid-lowering therapy before discharge after an acute ST-segment elevation myocardial infarction (STEMI), so why not start it right away — even in the cath ...

(DAPT) in patients treated with Firehawk stents was non-inferior to 12 months of DAPT for the primary composite event of ...

Antithrombotic therapy during percutaneous coronary intervention for ST-segment elevation myocardial infarction has evolved substantially over the past 15 years. With the results of the ATOLL trial, ...